转录因子STAT5A启动子荧光素酶报告基因质粒的构建及鉴定

doi:10.3969/j.issn.1004-616x.2022.01.010

癌变·畸变·突变 ›› 2022, Vol. 34 ›› Issue (1): 53-56,71.doi: 10.3969/j.issn.1004-616x.2022.01.010

转录因子STAT5A启动子荧光素酶报告基因质粒的构建及鉴定

陈敏娜^1,2, 李春兰², 刘静²

1. 汕头大学医学院附属肿瘤医院乳腺内科, 广东汕头 515041;
2. 汕头大学医学院广东省乳腺癌诊治研究重点实验室/长江学者实验室/生理学教研室, 广东汕头 515041

收稿日期:2021-07-06 修回日期:2021-12-28 出版日期:2022-01-31 发布日期:2022-02-15
通讯作者: 刘静,E-mail:jliu12@stu.edu.cn E-mail:jliu12@stu.edu.cn
作者简介:陈敏娜,E-mail:c_minna@163.com
基金资助:
广东省自然科学基金（2021A1515012180，2016A030312008）；汕头市医疗卫生科技计划项目（200604125265614，200617105260368）；汕头大学医学院附属肿瘤医院青年科研基金（2020A007）；广东省科技创新战略专项资金（汕府科2018-49，汕府科2019-132）

Construction and identification of luciferase reporter plasmids for the transcription factor STAT5A promoter

CHEN Minna^1,2, LI Chunlan², LIU Jing²

1. Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515041;
2. Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer/Changjiang Scholar's Laboratory/Department of Physiology, Shantou University Medical College, Shantou 515041, Guangdong, China

Received:2021-07-06 Revised:2021-12-28 Online:2022-01-31 Published:2022-02-15

摘要/Abstract

摘要： 目的： 利用分子克隆的方法构建转录因子STAT5A启动子荧光素酶报告基因质粒并鉴定其效应。方法： 以乳腺癌MCF7细胞基因组DNA为模板，采用PCR方法扩增STAT5A基因的启动子序列，并将其克隆至荧光素酶报告基因质粒pGL3-Enhancer中，经过菌液扩增、酶切、测序等方法获得目的质粒，并通过双荧光报告基因实验进一步验证其功能。结果： 构建的STAT5A启动子荧光素酶报告基因质粒pGL3-STAT5A-pro-luc-E序列正确，且具有转录活性。在双荧光报告基因实验中发现重组载体pGL3-STAT5A-pro-luc-E荧光素酶的相对活性约为阴性对照pGL3-Enhancer的8倍（P<0.01），而pGL3-STAT5A-pro-N-luc-E荧光素酶的相对活性约是阴性对照pGL3-Enhancer的6倍（P<0.01）。结论： 本项目成功构建了转录因子STAT5A启动子荧光素酶报告基因质粒，为进一步研究STAT信号转导及转录激活蛋白信号通路提供了重要的研究工具。

关键词: STAT5A, 启动子, 报告基因, 荧光素酶, PCR

Abstract: OBJECTIVE: To construct and to evaluate activities of luciferase reporter plasmids for transcription factor STAT5A promoter. METHODS: The sequence for the promoter region in STAT5A gene was amplified by PCR using genomic DNA of the breast cancer cell line MCF7 as a template and cloned into luciferase reporter plasmid pGL3-Enhancer. The target plasmid was amplified by bacterial fluid,examined by enzyme digestion and direct sequencing. The function of target plasmid was further verified by dual luciferase reporter gene assay. RESULTS: It was found that the cloned sequence of STAT5A promoter region in target plasmid was correct,and the target plasmid had transcriptional activities. Dual-luciferase assays found that the relative activities of the recombinant vector pGL3-STAT5A-pro-luc-E luciferase were about 8 times that of the negative control pGL3-Enhancer (P<0.01),and the pGL3-STAT5A-pro-N-luc-E luciferase activities were about 6 times that of the negative control pGL3-Enhancer (P<0.01). CONCLUSION: A luciferase reporter plasmid for transcription factor STAT5A promoter was successfully constructed. The plasmids would provide an important research tool for further study of STAT signal transduction and the transcriptional activator protein signaling pathway.

Key words: STAT5A, promoter, reporter gene, luciferase, PCR

中图分类号:

Q783

陈敏娜, 李春兰, 刘静. 转录因子STAT5A启动子荧光素酶报告基因质粒的构建及鉴定[J]. 癌变·畸变·突变, 2022, 34(1): 53-56,71.

CHEN Minna, LI Chunlan, LIU Jing. Construction and identification of luciferase reporter plasmids for the transcription factor STAT5A promoter[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 53-56,71.

参考文献

[1] 廖亮, 王琴容, 杨国辉. 重组双荧光素酶报告基因质粒psiCHECK-2-Intron构建转染及转染细胞萤火虫荧光素酶和海肾荧光素酶表达[J]. 山东医药, 2020, 60(9):32-35.
[2] SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2021[J]. CA A Cancer J Clin, 2021, 71(1):7-33.
[3] LIU X, ROBINSON G W, WAGNER K U, et al. Stat5a is mandatory for adult mammary gland development and lactogenesis[J]. Genes Dev, 1997, 11(2):179-186.
[4] CREAMER B A, SAKAMOTO K, SCHMIDT J W, et al. Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1[J]. Mol Cell Biol, 2010, 30(12):2957-2970.
[5] WAGNER K U, RUI H. Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression[J]. J Mammary Gland Biol Neoplasia, 2008, 13(1):93-103.
[6] VAFAIZADEH V, KLEMMT P, BRENDEL C, et al. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation[J]. Stem Cells, 2010, 28(5):928-938.
[7] HARICHARAN S, LI Y. STAT signaling in mammary gland differentiation, cell survival and tumorigenesis[J]. Mol Cell Endocrinol, 2014, 382(1):560-569.
[8] YAMASHITA H, NISHIO M, ANDO Y, et al. Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer[J]. Endocr Relat Cancer, 2006, 13(3):885-893.
[9] SULTAN A S, XIE J, LEBARON M J, et al. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells[J]. Oncogene, 2005, 24(5):746-760.
[10] PECK A R, WITKIEWICZ A K, LIU C, et al. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure[J]. J Clin Oncol, 2011, 29(18):2448-2458.
[11] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA:A Cancer J Clin, 2016, 66(2):115-132.
[12] CHEN H H, YU H I, YANG M H, et al. DDX3 activates CBC-eIF₃-Mediated translation of uORF-Containing oncogenic mRNAs to promote metastasis in hnscc[J]. Cancer Res, 2018, 78(16):4512-4523.

[1]	方煜彤, 张群琛, 洪超群, 陈春发, 陈炯玉, 张任栋, 吴俊东. 乳腺癌中miR-221、miR-222表达水平对GATA3和FOXA1蛋白的影响及其作用机制[J]. 癌变·畸变·突变, 2021, 33(6): 435-441,460.
[2]	李欣欣, 廖伟南, 庄少惠, 陈焕杰, 陈君填, 章斐然, 李威. 白介素17与上皮间质转化相关标志物在左右半结肠癌中的表达及其意义[J]. 癌变·畸变·突变, 2019, 31(4): 315-318.
[3]	朱萌, 翟华亮, 赵婉莹, 张宁, 和水祥. 转录因子KLF4与miR-106a的调控关系及其对人胃癌细胞迁移的影响[J]. 癌变·畸变·突变, 2018, 30(5): 339-344.
[4]	车碧众, 董广柱, 信丽丽. 热休克蛋白基因启动子报告基因技术评估环境污染物毒性作用的研究进展[J]. 癌变·畸变·突变, 2017, 29(6): 476-478,482.
[5]	龚瑜, 杨其昌, 袁荣华, 周峰, 李国利. 胃癌组织与血清miR-126的表达及临床意义[J]. 癌变·畸变·突变, 2017, 29(4): 272-276,283.
[6]	郭志兰, 车路阳, 李晶哲, 吴双, 孙震晓, 刘长振. Metridia荧光素酶检测条件的优化[J]. 癌变·畸变·突变, 2016, 28(6): 438-442.
[7]	Bernd Kaina. 甲基化抗肿瘤药物治疗中的DNA修复:治疗效果与健康结局[J]. 癌变·畸变·突变, 2016, 28(5): 333-341,347.
[8]	程琳, 孙平楠, 谢庆东, 周小玲. 预扩增qPCR方法检测少量小鼠早期胚胎细胞中DNA甲基化相关基因的表达[J]. 癌变·畸变·突变, 2016, 28(1): 51-55.
[9]	李琳, 李孝鑫, 林仲武, 扈江伟, 张学清, 沈丽萍, 常诚, 陈英, 葛银林, 王治东. POLH mRNA作为辐射损伤分子生物标志物的可行性研究[J]. 癌变·畸变·突变, 2015, 27(6): 421-425,431.
[10]	封杰, 刘文斌, 陈洪强, 黄永胜, 韩飞, 曹佳, 刘晋祎. 肺癌患者MPDZ基因异常甲基化的研究[J]. 癌变·畸变·突变, 2015, 27(6): 437-440.
[11]	何洁, 万经海, 李学记, 钱海鹏, 孟肖利, 郝佳洁, 徐昕, 王明荣. 胶质瘤中端粒酶逆转录酶启动子区突变分析及其预后意义[J]. 癌变·畸变·突变, 2015, 27(5): 361-365.
[12]	杨少哲, 石海军, 褚欣然, 周小玲, 孙平楠. 一种简便的高通量细胞内GFP报告基因检测方法[J]. 癌变·畸变·突变, 2015, 27(5): 394-398,403.
[13]	史荣辉, 韩飞, 董严, 张明谦, 姜晓, 尹俐, 刘文斌, 曹佳, 刘晋祎. SOX30基因在结直肠癌中的表达与甲基化分析[J]. 癌变·畸变·突变, 2015, 27(3): 168-171,176.
[14]	李夏君，杨淼，董自成，刘冉，尹立红，浦跃朴. LncRNA-UCA1与淮安食管癌发病风险的初步研究[J]. 癌变·畸变·突变, 2014, 26(6): 407-411.
[15]	刘海英，黄青，董静文，李莉*. 胚胎癌F9细胞中Oct4对miR-302启动子的调控作用[J]. 癌变·畸变·突变, 2014, 26(4): 258-265.

转录因子STAT5A启动子荧光素酶报告基因质粒的构建及鉴定

Construction and identification of luciferase reporter plasmids for the transcription factor STAT5A promoter

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价